TETRA Technologies (TTI) Q4 2025 earnings summary

Executive summary

• Achieved record financial performance in 2025, with full-year revenue up 5% to $631 million and Adjusted EBITDA up 14% to $113.6 million, despite challenging U.S. oil and gas market and global volatility.

• Completion fluids, West Memphis plant, and calcium chloride businesses all set revenue and adjusted EBITDA records, with significant growth in produced water recycling and desalination.

• Significant progress on strategic projects, including new bromine plant, expansion into desalination and magnesium production, and patent protection for desalination technology.

• Transition in CFO role with a planned, orderly handover to ensure continuity.

• Loss from continuing operations in Q4 was $15.3 million due to $18.7 million in unusual charges; adjusted net income per share was $0.02 for Q4 and $0.26 for the year.

Financial highlights

• Q4 revenues were $146.7 million, up 9% year-over-year; full-year revenues reached $631 million, the highest in a decade.

• Completion fluids and products revenue in Q4 was $83.7 million, up 22% year-over-year; adjusted EBITDA margin at 28.2%.

• Free cash flow from base business was $83 million for 2025, exceeding the $50 million target.

• Consolidated free cash flow, including Arkansas investments, was $33 million; year-end cash was $72.6 million; net debt reduced to $109 million; net leverage ratio improved to 1.1x.

• Q4 Adjusted EBITDA was $20.4 million; full-year Adjusted EBITDA margin was 18.0%.

Outlook and guidance

• Expect modest overall growth in 2026, with incremental revenue from electrolyte business and Argentina contracts.

• Completion fluids and products adjusted EBITDA margins projected at 25%-30% in 2026 due to higher bromine costs.

• Water and flowback services margins expected to improve to mid-teens in 2026, driven by technology and international growth.

• Bromine plant on track for Q4 2027 completion, with potential for earlier delivery.

• Strategic goal to double revenue and triple Adjusted EBITDA by 2030 remains on track.